methotrexate has been researched along with Left Ventricular Dysfunction in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giles, JT; Hirano, M; Kobayashi, H; Kobayashi, Y | 1 |
| Aftimos, P; Ameye, L; Beauduin, M; Bejarano Hernández, S; Cornez, N; de Azambuja, E; Delhaye, F; Diaz, M; Focan, C; Lemort, M; Paesmans, M; Piccart-Gebhart, M; Shih-Li, C; Suter, T; Vandenbossche, S; Vindevoghel, A | 1 |
| Prior, JO; Pruvot, E; Rutz, T; Vionnet, J | 1 |
| Blegvad, J; Ellingsen, T; Hedemann-Nielsen, A; Herly, M; Kristensen, LD; Laurbjerg, TB; Løgstrup, BB; Masic, D; Urbonaviciene, G | 1 |
| Coccaro, M; Gallucci, G | 1 |
| Alkady, EA; Helmy, HA; Mohamed-Hussein, AA | 1 |
| Bodolay, E; Hegedus, I; Szegedi, G; Végh, J; Zeher, M | 1 |
| Balduzzi, A; Cardillo, A; Colleoni, M; Ghisini, R; Goldhirsch, A; Orlando, L; Peruzzotti, G; Pietri, E; Rocca, A; Torrisi, R | 1 |
| Albain, KS; Dakhil, SR; Ganz, PA; Giguere, JK; Goodwin, JW; Hussey, MA; Hutchins, LF; Martino, S; Moinpour, CM; Unger, JM | 1 |
| Beaufort-Krol, GC; Bink-Boelkens, MT; Elzenga, NJ; Kamps, WA; Kengen, RA; Postma, A; Schasfoort-van Leeuwen, MJ; Schraffordt koops, H | 1 |
3 trial(s) available for methotrexate and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Echocardiography; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Survival Rate; Ventricular Dysfunction, Left | 2015 |
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Gene Amplification; Genes, erbB-2; Humans; Immunization, Passive; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Proteins; Neutropenia; Receptor, ErbB-2; Remission Induction; Trastuzumab; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Prognosis; Receptor, ErbB-2; Survival Rate; Survivors; Tamoxifen; Ventricular Dysfunction, Left | 2008 |
7 other study(ies) available for methotrexate and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Left ventricular regional dysfunction using cardiac magnetic resonance imaging in rheumatoid arthritis patients without cardiac symptoms: comparison between methotrexate and biologics treatment groups.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Ventricular Dysfunction, Left | 2014 |
Non-Hodgkin lymphoma and idiopathic inflammatory cardiomyopathy.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Coronary Angiography; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Methotrexate; Middle Aged; Multimodal Imaging; Myocarditis; Positron Emission Tomography Computed Tomography; Recurrence; Ventricular Dysfunction, Left | 2016 |
Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Denmark; Disease Progression; Echocardiography; Female; Humans; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Tomography, X-Ray Computed; Vascular Calcification; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Late cardiac effects of adjuvant radiotherapy and chemotherapy in early breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Prognosis; Receptor, ErbB-2; Survival Rate; Survivors; Tamoxifen; Ventricular Dysfunction, Left | 2008 |
Assessment of cardiac and pulmonary function in children with juvenile idiopathic arthritis.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Blood Pressure; Case-Control Studies; Child; Child, Preschool; Echocardiography, Doppler; Female; Forced Expiratory Volume; Heart; Humans; Lung; Lung Diseases; Male; Methotrexate; Respiratory Function Tests; Risk Factors; Ventricular Dysfunction, Left; Vital Capacity | 2012 |
Diastolic function of the heart in mixed connective tissue disease.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclophosphamide; Diastole; Drug Therapy, Combination; Echocardiography, Doppler; Female; Glucocorticoids; Heart Ventricles; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mixed Connective Tissue Disease; Myocardium; Pulse Therapy, Drug; Severity of Illness Index; Sulfasalazine; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2007 |
Late cardiotoxicity after treatment for a malignant bone tumor.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Bleomycin; Body Surface Area; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Dilatation, Pathologic; Doxorubicin; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart; Heart Diseases; Heart Rate; Humans; Male; Methotrexate; Middle Aged; Myocardium; Radionuclide Angiography; Stroke Volume; Survivors; Ventricular Dysfunction, Left | 1996 |